This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,330.50 contract is for the supply of Fasenra 30 mg/ml syringes, a biologic medication used to treat severe asthma.
The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. As a woman-owned small business, DMS Pharmaceutical Group is able to secure direct federal contract awards without set-aside designations. This delivery order has an ultimate completion date of September 19, 2024.
Generated 12/18/24, 9:49 AM